EMPA-REG Outcome: results that question

被引：0
|
作者：
Pouchain, Denis [1 ]
机构：
[1] UFR Tours, Dept Univ Med Gen, Tours, France
来源：
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE | 2016年 / 27卷 / 128期
关键词：
Empagliflozin; Hypoglycemic agents; Randomized controlled trials;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：278 / 282
页数：5
相关论文
共 50 条
  • [41] Mortality Reduction in EMPA-REG OUTCOME Trial: Beyond the Antidiabetes Effect
    Suissa, Samy
    DIABETES CARE, 2018, 41 (02) : 219 - 223
  • [42] EMPA-REG OUTCOME and beyond: the long game of cardiovascular risk reduction
    Aroda, Vanita R.
    Sabatine, Marc S.
    LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (12): : 932 - 933
  • [43] The interim experts' council resolution on the EMPA-REG OUTCOME trial issues
    Shestakova, M. V.
    Boytsov, S. A.
    Drapkina, O. M.
    Demidova, T. Yu.
    Drexel, H.
    Antsiferov, M. B.
    Petunina, N. A.
    Chernikova, I. A.
    Kalashnikov, V. Yu.
    Bardymova, T. P.
    Protasov, V. K.
    Babenko, A. Yu.
    Ruyatkina, L. A.
    Klimontov, V. V.
    Salukhov, V. V.
    Fadeev, V. V.
    Karpov, Yu. A.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2016, 12 (02) : 186 - 190
  • [44] Retinopathy Outcomes With Empagliflozin Versus Placebo in the EMPA-REG OUTCOME Trial
    Inzucchi, Silvio E.
    Wanner, Christoph
    Hehnke, Uwe
    Zwiener, Isabella
    Kaspers, Stefan
    Clark, Douglas
    George, Jyothis T.
    Zinman, Bernard
    DIABETES CARE, 2019, 42 (04) : E53 - E55
  • [45] Efficacy and safety of empagliflozin in older patients in the EMPA-REG OUTCOME® trial
    Monteiro, Pedro
    Bergenstal, Richard M.
    Toural, Elvira
    Inzucchi, Silvio
    Zinman, Bernard
    Hantel, Stefan
    Kis, Sanja Giljanovic
    Kaspers, Stefan
    George, Jyothis T.
    Fitchett, David
    AGE AND AGEING, 2019, 48 (06) : 859 - 866
  • [46] CV Protection in the EMPA-REG OUTCOME Trial: A "Thrifty Substrate" Hypothesis
    Ferrannini, Ele
    Mark, Michael
    Mayoux, Eric
    DIABETES CARE, 2016, 39 (07) : 1108 - 1114
  • [47] Cardiovascular outcomes according to LDL cholesterol levels in EMPA-REG OUTCOME
    Langslet, G.
    Zinman, B.
    Wanner, C.
    Hantel, S.
    Espadero, R. -M.
    Johansen, O. E.
    Fitchett, D.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1192 - 1192
  • [48] The EMPA-REG outcome study: critical appraisal and potential clinical implications
    Perseghin, Gianluca
    Solini, Anna
    CARDIOVASCULAR DIABETOLOGY, 2016, 15
  • [49] The EMPA-REG outcome study: critical appraisal and potential clinical implications
    Gianluca Perseghin
    Anna Solini
    Cardiovascular Diabetology, 15
  • [50] CARDIOVASCULAR OUTCOMES ACCORDING TO LDL CHOLESTEROL LEVELS IN EMPA-REG OUTCOME
    Lee, Dae Wook
    Langslet, Gisle
    Zinman, Bernard
    Wanner, Christoph
    Hantel, Stefan
    Espadero, Rosa-Maria
    Johansen, Odd Erik
    Fitchett, David
    JOURNAL OF HYPERTENSION, 2016, 34 : E518 - E518
12345